GlaxoSmithKline Pharmaceuticals has launched Jemperli and Zejula in India, pioneering precision therapies for gynaecological ...

Jemperli is the first and only approved programmed death receptor-1 (PD-1) immunotherapy for the second-line treatment of ...

Endometrial cancer is hard to detect. Here are some signs of endometrial cancer worth bringing to your doctor's attention, ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast cancers are treated in the future ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

Studies show that people receiving tamoxifen, a highly effective and commonly used therapy to treat breast cancer, face a 2- ...

Loni Anderson's cause of death was metastatic uterine leiomyosarcoma, a rare and aggressive form of cancer. She passed away ...

GlaxoSmithKline (GSK) has entered India's oncology sector with the launch of Jemperli and Zejula. These therapies address the increasing need for specialized cancer treatments.

Karen Thursby, a Darlington -based yoga teacher who lost her mother Lola to bile duct cancer in 2017, has been organising ...

DelveInsight's,“ Advanced Endometrial Cancer Pipeline Insight 2025” report provides comprehensive insights about 25+ ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer ...